StonvexLoading…
StonvexStonvexStonvexCore line items from BMRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $949.01M | $766.21M | $3.22B | $2.35B | $1.57B |
Operating Income | Not available | $129.64M | $409.48M | $454.09M | $500.78M |
Net Income | Not available | $105.53M | $348.90M | $395.47M | $426.22M |
EPS (Diluted) | $0.81 | $0.54 | $1.80 | $2.04 | $2.19 |
Total Assets | Not available | $8.59B | $7.59B | $7.61B | $7.46B |
Total Liabilities | Not available | $2.38B | $1.51B | $1.56B | $1.43B |
Cash & Equivalents | Not available | $2.22B | $1.31B | $1.25B | $1.21B |
Free Cash Flow OCF − CapEx | Not available | $199.73M | $724.96M | $666.03M | $325.80M |
Shares Outstanding | Not available | 193.27M | 192.30M | 192.10M | 192.00M |